Health Care/Hospital

PVmed Raises US $14 Million Series A Funding from Cherami, Philips, JHF, COCOCAPITAL, and Strategy Capital

Will Support Rapid Expansion of PVmed's AI Cancer Treatment Product Portfolio GUANGZHOU, China, Dec. 22, 2022 /PRNewswire/ -- Perception Vision Medical Technologies Co., Ltd. (PVmed), a global artificial intelligence (AI) cancer treatment company, headquartered inGuangzhou, China, has secured US ...

2022-12-23 11:31 2133

JUNIPER BIOLOGICS WINS M&A AWARD 2022 BY ACQUISITION INTERNATIONAL

Best Cell & Gene Therapy Acquisition 2022: Juniper Biologics/Kolon Life Science SINGAPORE, Dec. 23, 2022 /PRNewswire/ -- Singapore-headquartered Juniper Biologics Pte Ltd , a science-led healthcare company focused on commercialising novel therapies, was awarded ...

2022-12-23 09:35 2911

Antengene Announces NDA Submission for XPOVIO® in Macau, Malaysia and Thailand for Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Diffuse Large B-cell Lymphoma

SHANGHAI and HONG KONG, Dec. 23, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedicated to discovering, developing and commercializing first-in-class and/or best-in-class therapeutics in hem...

2022-12-23 08:30 2808

Ubitus and Smart Surgery enable doctors to practice robotic surgery with VR streaming

TOKYO, Dec. 22, 2022 /PRNewswire/ -- Ubitus K.K. (hereinafter Ubitus), a world-leading metaverse solution provider, supports Smart Surgery Technology to roll out its VR driven surgery simulation application – Sim Surgery. Smart Surgery Technology successfully demonstrated this innovative product ...

2022-12-22 22:00 2476

FDA agrees to Actinogen six-month Phase 2b Alzheimer's Disease trial

Exploring Xanamem® and the "cortisol hypothesis" for more than 6 million Americans suffering from Alzheimer's Disease[1]  SYDNEY, Dec. 22, 2022 /PRNewswire/ -- Actinogen Medical Limited (ASX: ACW) is pleased to announce receipt today of agreement from the US Food and Drug Administration (FDA) to...

2022-12-22 20:30 1802

P3 Research secures investment from Genesis Capital to accelerate expansion

* P3 is a leading New Zealand clinical trial site network founded in 1998 * With sites in seven locations throughout New Zealand, P3's clients range from large multi-nationals to small biotechs globally * Genesis Capital has become the major shareholder of the clinical trials group alongside...

2022-12-22 19:36 2865

IASO Bio Announces U.S. FDA Approval of Clinical Trial Application for BCMA CAR-T CT103A for Relapsed/Refractory Multiple Myeloma

SHANGHAI and NANJING, China and SAN JOSE, Calif., Dec. 22, 2022 /PRNewswire/ -- IASO Biotherapeutics (IASO Bio), a clinical-stage biopharmaceutical company engaged in discovering, developing, and manufacturing innovative cell therapies and antibody products,, today announced that the Investiga...

2022-12-22 16:38 1867

New STIC trial data shows longer overall survival for therapy selection based on CELLSEARCH® CTC count in patients with metastatic breast cancer

Integration of CTC (Circulating Tumor Cell) enumeration* to decide between endocrine therapy and chemotherapy may lead to improved clinical outcomes and quality of life for patients with oestrogen receptor (ER) positive)/human epidermal growth factor receptor (HER) 2 negative metastatic breast ca...

2022-12-22 16:00 3991

Gemini Rosemont adds Peninsula Life Science Center eight-story office building to portfolio in all cash transaction

LOS ANGELES, Dec. 22, 2022 /PRNewswire/ -- Gemini Rosemont Commercial Real Estate, a vertically integrated real estate investment management firm specializing in Class A multi-tenant office and luxury residential properties, has acquired Peninsula Life Science Center for$59,350,000.

2022-12-22 11:27 4133

Everest Medicines' Licensing Partner Pfizer Announces FDA and EMA Acceptance of Etrasimod Regulatory Submissions for Ulcerative Colitis

SHANGHAI, Dec. 22, 2022 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK) announced today that its licensing partner, Pfizer Inc. (NYSE: PFE) has received acceptance from the U.S. Food and Drug Administration (FDA) for review a New Drug Application (NDA) for etrasimod for individuals living with ...

2022-12-22 08:00 3284

ZIRCON Phase III Renal Cancer Study to be Presented at ASCO GU along with Theranostic Pipeline Advances

* Complete data from global Phase III ZIRCON study of Telix's investigational imaging agent TLX250-CDx in clear cell renal cell carcinoma (ccRCC) will be presented at American Society of Clinical Oncology (ASCO) Genitourinary (GU) Cancers Symposium (ASCO GU) inFebruary 2023 * Telix pipeline...

2022-12-22 06:04 2161

Nuevocor to Present at Biotech Showcase during JPM week and at Keystone Symposium on Heart Development and Disease

SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- Nuevocor , a pre-clinical stage cardiac gene therapy company, announced today that it will be presenting at the Biotech Showcase during JPM week, taking place inSan Francisco, CA, USA from January 9 to 11, 2023. Nuevocor will als...

2022-12-21 22:00 2109

The Top 4 Best Places to Work in Thailand for 2022 revealed

BANGKOK, Dec. 21, 2022 /PRNewswire/ -- Novo Nordisk, AIA, Jardine Schindler Thailand, LCIT are recognized as the top 4 best places to work inThailand for 2022 according to the annual prestigious "Best Places to Work" certification program. Novo Nordisk Thailand was awarded the top position follo...

2022-12-21 21:51 2020

Waterdrop Chief Actuary Hui Teng: Good Products and Services Are the Underlying Logic of High-quality Transformation for Health Insurance

BEIJING, Dec. 21, 2022 /PRNewswire/ -- At the recently held 2022 China Insurance and Aged Healthcare Forum,Hui Teng, Chief Actuary of Waterdrop Inc., was invited to give a speech titled Good Products and Services Are the Underlying Logic of High-quality Transformation for Health Insurance. He sha...

2022-12-21 21:30 3052

CGTN: 'New Approaches': How China stepped up its COVID-19 treatments

BEIJING, Dec. 21, 2022 /PRNewswire/ -- China has been racing against the clock in developing COVID-19 drugs while promoting vaccination – one for saving lives and the other for providing broad protection. While the stringent COVID-19 containment measures of the past three years helpedChina evade...

2022-12-21 18:51 2186

CPIC: "CPIC Elite Club" Creates High Quality Services Escorts for Healthy Living

HONG KONG, Dec. 21, 2022 /PRNewswire/ -- The insurance industry is a "stabiliser" for social development and a "booster" for economic growth. In recent years,China's insurance industry has been growing rapidly. Since 2017 in whichChina's premium income exceeded that of Japan, China's premium inco...

2022-12-21 15:26 3644

I Peace, Inc. honored in BioSpectrum Asia Excellence Award 2022 with "Special Recognition in Cell Therapy"

PALO ALTO, Calif., Dec. 21, 2022 /PRNewswire/ -- I Peace, Inc. ( https://www.ipeace.com ), has been awarded a "Special Recognition in Cell Therapy" during BioSpectrum Asia Excellence Award 2022 ceremony held inSingapore on December 2 ( https://www.biospectrumasia.com/news/...

2022-12-21 15:10 1817

Medidata awarded International Innovation Award for Medidata Sensor Cloud

SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- For the third consecutive year, Medidata, a Dassault Systèmes company, was awarded the International Innovation Award. This year, the Medidata Sensor Cloud won the award under the Service and Solution category. Sensor Cloud provides cutting-edge data inges...

2022-12-21 14:44 2120

QureBio Ltd. to Present its Q-1802 Clinical Phase Ⅰ Data at 2023 ASCO-GI Meetings

SHANGHAI, Dec. 20, 2022 /PRNewswire/ --  QureBio Ltd., a clinical-stage biopharmaceutical company focusing on development of bispecific antibodies and other engineeredBiopharmaceuticals for the treatment of cancer, inflammation, and other serious disorders, today announced that Phase Ⅰ Clinical D...

2022-12-21 10:30 2183

Singapore-based lifestyle app CardsPal boosts fitness offering through partnership with AI-powered fitness coach ActivEdge

SINGAPORE, Dec. 21, 2022 /PRNewswire/ -- CardsPal, the lifestyle deals discovery app, partners with ActivEdge, a technology-first fitness app powered by artificial intelligence, to lower the barriers of entry to personalised fitness programmes for fitness enthusiasts. Access to ActivEdge is a fra...

2022-12-21 09:33 2329
1 ... 212213214215216217218 ... 805